# Cerebrolysin

*Also known as: Cerebrolysin*

Mixture of low-molecular-weight neuropeptides and amino acids researched for stroke and cognitive recovery.

## Overview

Cerebrolysin is a porcine brain-derived preparation containing low-molecular-weight neuropeptides and amino acids. It is a complex mixture rather than a single peptide, and it is proposed to support neuronal survival, neurogenesis, and synaptic plasticity. It is studied for stroke recovery, traumatic brain injury, and cognitive decline. The mechanism is multifactorial, mimicking endogenous neurotrophic factors like NGF and BDNF. Because it is a blend of short-lived fragments, the estimated half-life is roughly one hour, with about 40% bioavailability. Cerebrolysin is approved in several countries across Europe and Asia, but not by the FDA. There is a real, if uneven, clinical evidence base, with trials in stroke and dementia showing mixed results.

## Pharmacokinetics

- **Model tier:** simple
- **Half-life:** 0.0 days (0.96 hours)
- **Bioavailability:** 40%

## Dosing

- **Default dose:** 5 mg
- **Typical range:** 1–10 mg
- **Units:** ng/mL

## Source

- **Label:** Estimated (peptide blend)
- **Notes:** Pig-brain hydrolysate of neuropeptides; mixture of short-lived fragments.

**Tags:** cognitive, recovery-healing

---

**Canonical URL:** https://anabolicdex.com/compounds/cerebrolysin
**Plot:** https://anabolicdex.com/plot?compound=cerebrolysin